News releases Year None2026202520242023202220212019 May 14, 2026 Pyxis Oncology Reports First Quarter 2026 Financial Results and Advances MICVO Toward Key 2026 Clinical Milestones PDF Version May 13, 2026 Pyxis Oncology to Participate in Upcoming Investor Conferences PDF Version May 07, 2026 Pyxis Oncology Appoints Nelson Azoulay as Chief Business Officer PDF Version Apr 17, 2026 Pyxis Oncology to Present New Preclinical Data Showing Synergistic Anti-Tumor Activity in a HNSCC model with maMICVO in Combination with Anti-PD-1 at AACR 2026 PDF Version Mar 23, 2026 Pyxis Oncology Provides Business Update and Reports Fourth Quarter and Full Year 2025 Financial Results PDF Version Feb 03, 2026 Pyxis Oncology Announces Interim CEO Appointment and Leadership Transition to Support Strategic Focus and Program Continuity PDF Version
Year None2026202520242023202220212019 May 14, 2026 Pyxis Oncology Reports First Quarter 2026 Financial Results and Advances MICVO Toward Key 2026 Clinical Milestones PDF Version May 13, 2026 Pyxis Oncology to Participate in Upcoming Investor Conferences PDF Version May 07, 2026 Pyxis Oncology Appoints Nelson Azoulay as Chief Business Officer PDF Version Apr 17, 2026 Pyxis Oncology to Present New Preclinical Data Showing Synergistic Anti-Tumor Activity in a HNSCC model with maMICVO in Combination with Anti-PD-1 at AACR 2026 PDF Version Mar 23, 2026 Pyxis Oncology Provides Business Update and Reports Fourth Quarter and Full Year 2025 Financial Results PDF Version Feb 03, 2026 Pyxis Oncology Announces Interim CEO Appointment and Leadership Transition to Support Strategic Focus and Program Continuity PDF Version
